Precipio Inc (PRPO) reports positive cash flow and revenue growth, while addressing challenges in its product division and ...

Q4 2024 Earnings Call Transcript March 31, 2025 Operator: Welcome to the Precipio Q4 and Year-End 2024 Shareholder Update ...

Precipio ( NASDAQ:PRPO ) Full Year 2024 Results Key Financial Results Revenue: US$18.5m (up 22% from FY 2023). Net... Conference Call to be held on March 31st, 2025 at 5:00 PM ESTNEW HAVEN ...

NEW HAVEN, Conn., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.(NASDAQ: PRPO), announces that it has achieved two important financial goals in the last ...

Precipio Inc. reported a strong performance in Q4 2024, with nearly 26% revenue growth compared to the previous year. The company also achieved positive adjusted EBITDA and cash flow. According to ...

Welcome to the Precipio Q4 and Year-End 2024 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that the conference is being ...

NEW HAVEN, Conn., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it has achieved two important financial goals in the last quarter ...

Precipio Inc. reported a strong performance in Q4 2024, with nearly 26% revenue growth compared to the previous year. The company also achieved positive adjusted EBITDA and cash flow. According to ...

Positive Adjusted EBITDA – Precipio reports (unaudited) Adjusted EBITDA of $0.4M for Q4-2024. Adjusted EBITDA is a non-GAAP metric that comprises EBITDA, less non-cash stock-based compensation expense ...